PASITHEA THERAPEUTICS CORP. Depreciation
PASITHEA THERAPEUTICS CORP. (KTTA) reported Depreciation of $32.42 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. depreciation for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. depreciation for the quarter ending 2025-09-30 was $24.05K, a 409.99% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. depreciation for the quarter ending 2025-06-30 was $4.00K, a 20.00% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. depreciation for the quarter ending 2025-03-31 was $4.82K, a 2.20% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. depreciation for fiscal 2025 was $32.42K, a 71.86% increase from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. depreciation for fiscal 2024 was $18.86K, a 3.14% increase from fiscal 2023.
- PASITHEA THERAPEUTICS CORP. depreciation for fiscal 2023 was $18.29K, a 259.05% increase from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. depreciation for fiscal 2022 was $5.09K, a 269.40% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $24.05K derived: sum of 2 quarters · filed 2026-03-30 | $28.05K derived: sum of 3 quarters · filed 2026-03-30 | $32.42K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $24.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $28.05K derived: sum of 2 quarters · filed 2025-11-13 | $32.42K 10-Q · filed 2025-11-13 | $37.59K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2025-06-30 | $4.00K 10-Q · filed 2025-08-14 | $8.37K 10-Q · filed 2026-08-14 | $13.54K derived: sum of 3 quarters · filed 2026-05-15 | $18.25K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2025-03-31 | $4.82K 10-Q · filed 2026-05-15 | $4.17K 10-Q · filed 2025-05-15 | $9.54K derived: sum of 2 quarters · filed 2026-05-15 | $14.25K derived: sum of 3 quarters · filed 2026-05-15 | $19.25K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $4.72K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $9.43K derived: sum of 2 quarters · filed 2026-03-30 | $14.43K derived: sum of 3 quarters · filed 2026-03-30 | $18.86K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $4.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.72K derived: sum of 2 quarters · filed 2025-11-13 | $14.15K 10-Q · filed 2025-11-13 | $19.11K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $5.00K 10-Q · filed 2025-08-14 | $9.43K 10-Q · filed 2025-08-14 | $14.40K derived: sum of 3 quarters · filed 2025-08-14 | $19.11K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $4.72K 10-Q · filed 2025-05-15 | $9.40K derived: sum of 2 quarters · filed 2025-05-15 | $14.11K derived: sum of 3 quarters · filed 2025-05-15 | $18.83K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $4.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $9.39K derived: sum of 2 quarters · filed 2025-03-24 | $14.11K derived: sum of 3 quarters · filed 2025-03-24 | $18.29K 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $4.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $9.43K derived: sum of 2 quarters · filed 2024-11-13 | $13.61K 10-Q · filed 2024-11-13 | $17.75K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $4.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $8.89K 10-Q · filed 2024-08-13 | $13.03K derived: sum of 3 quarters · filed 2024-08-13 | $13.03K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $4.18K 10-Q · filed 2024-05-14 | $8.32K derived: sum of 2 quarters · filed 2024-05-14 | $8.32K derived: sum of 3 quarters · filed 2024-05-14 | $4.26K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $4.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $4.14K derived: sum of 2 quarters · filed 2024-03-29 | $80.00 derived: sum of 3 quarters · filed 2024-03-29 | $5.09K 10-K · filed 2024-03-29 | $31.52K 10-K · filed 2023-03-30 | |||
| 2022-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$4.06K derived: sum of 2 quarters · filed 2023-11-13 | $956.00 10-Q · filed 2023-11-13 | $32.47K 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$4.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $957.00 10-Q · filed 2023-08-11 | $15.80K 10-Q · filed 2022-08-15 | |||||
| 2022-03-31 | $5.01K 10-Q · filed 2022-05-16 | |||||||
| 2021-12-31 | $1.38K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |